Results 281 to 290 of about 32,339,977 (323)

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

When a model gives you mixed signals: cognitive effects and visual behavior. [PDF]

open access: yesProcess Sci
Abbad-Andaloussi A   +4 more
europepmc   +1 more source

Cancer 3D Models: Essential Tools for Understanding and Overcoming Drug Resistance. [PDF]

open access: yesOncol Res
Jovanović Stojanov S   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy